DRUG2DRUGS
LIVE

Serial Number

98146259

Owner

FUJIFILM CORPORATION

Attorney

Suzanne M. Hengl

Filing Date

Aug 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DRUG2DRUGS Trademark

Serial Number: 98146259 • Registration: 7618639

DRUG2DRUGS is a trademark filed by FUJIFILM CORPORATION on August 23, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

FUJIFILM CORPORATION (529 trademarks)

26-30, NISHIAZABU 2-CHOME, MINATO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

August 23, 2023

Registration Date

December 24, 2024

Published for Opposition

October 22, 2024

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Chemical additives for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in scientific and biotechnological research and development

Providing medical information relating to diagnostic, prevention and healing property of medicines; providing medical information relating to pharmaceuticals and compounds which is a source of pharmaceuticals; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus; pharmaceutical compounding services

Development of pharmaceutical preparations and medicines; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Testing of pharmaceuticals; design, development and research of chemicals, pharmaceuticals and chemical compounds; consultancy and information services relating to design, development and research of chemicals, pharmaceuticals and chemical compounds; analysis, testing and inspection of chemicals, pharmaceuticals and chemical compounds; consultancy and information services relating to analysis, testing and inspection of chemicals, pharmaceuticals and chemical compounds; pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; pharmaceutical research services; consulting services in the field of pharmaceutical research; testing, inspection or research of pharmaceuticals; pharmaceutical research and development; research of molecule design; consultancy and information services relating to research of molecule design; scientific research and testing surveys in the nature of research on the subject of pharmaceuticals, pharmaceutical research and development and pharmaceutical drug development services; providing computer programs, namely, providing on-line non-downloadable software for design, development and research of compounds which are a source of pharmaceuticals in the field of development of new drugs; designing of machines, apparatus, instruments or systems composed of such machines, apparatus and instruments; rental of laboratory apparatus and instruments

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2024 CRFA
ASSIGNED TO LIE
Sep 8, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 11, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 6, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 6, 2024 GNSL
SUSPENSION LETTER WRITTEN
Mar 6, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 15, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2023 NWOS
NEW APPLICATION ENTERED
Aug 26, 2023 NWAP